← All trials
NCT01663077
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2012
- Primary completion
- Nov 1, 2016
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Technion UniversityLead sponsor
- Ben Gurion UniversityOverall official - principal investigator
- The Nazareth Hospital, IsraelOverall official - principal investigator
- Technion UniversityStudy director
- Sha'ar Menashe Mental Health CenterOverall official - principal investigator
- Emek Medical CenterCollaborator
- The Nazareth Hospital, IsraelCollaborator
- Technion UniversityReponsible party - principal investigator
- Ben Gurion UniversityCollaborator
- Sha'ar Menashe Mental Health CenterCollaborator
- Technion UniversityOverall official - principal investigator
- Technion UniversityCollaborator
- Emek Medical CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.